Chronic Transcranial Direct Current Stimulation in Patients With Systemic Autoimmune Myopathies
University of Sao Paulo
40 participants
Dec 12, 2020
INTERVENTIONAL
Conditions
Summary
Systemic autoimmune myopathies are rheumatic diseases that affect the striatum skeletal muscles. The transcranial direct current stimulation technique has been frequent, for example, in patients with ischemic stroke or for the optimization of muscular performance in athletes. However, to date, there are no studies evaluating this technique in patients with systemic autoimmune myopathies. Therefore, the main objective of the present prospective, randomized, double-blind, placebo-controlled study is to evaluate the safety and efficacy of the application of chronic transcranial direct current stimulation sessions - associated with aerobic exercises - in the patients with systemic autoimmune myopathies.
Eligibility
Inclusion Criteria2
- Classification criteria - EULAR/ACR 2017
- Classification critera - Connors et al.
Exclusion Criteria6
- Neoplasia
- Using heart pacemarker
- Using visceral metalic clips
- Infections (HIV, HTLV-1, Hepatitis, etc)
- Pregnance
- Previous historical of convulsions or epilepsies
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Chronic transcranial direct current stimulation
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04678635